跳至主要内容
临床试验/NCT05441020
NCT05441020已完成不适用

Development, Feasibility Testing and Validation of a Survey Set to Measure Patient-Reported Outcomes Among Hemodialysis Patients in Turkey

Fresenius Medical Care Deutschland GmbH7 个研究点 分布在 1 个国家目标入组 173 人开始时间: 2022年11月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
173
试验地点
7
主要终点
Validation of Patient Reported Outcome Measures Information System-29 (PROMIS-29)

研究概览

简要总结

Development, feasibility testing and validation of a Survey Set to Measure Patient-Reported Outcomes among Hemodialysis Patients in Turkey: Creating and testing an electronic patient questionnaire that is suitable to measure health-related quality of life in Turkish dialysis patients in clinical as well as in home care settings.

详细描述

Individuals with chronic kidney disease represent a growing population in adult and pediatric practices. This has resulted in a drive to optimize patient care and outcomes. Historically, healthcare outcomes focused on morbidity, mortality or complication rates, but failed to provide meaningful data on the value of medicine to patients and the quality of life gained or lost. Several studies have revealed that treatments aimed at minimizing morbidity and mortality in end-stage renal disease (ESRD) have very often been ineffective. Therefore, attention to HRQOL among ESRD patients is crucial.

The aim of this pilot study is creating and testing an electronic patient questionnaire that is suitable to measure health-related quality of life in Turkish dialysis patients. This questionnaire consists of the PROMIS Cognitive Function and Abilities Subset, the PROMIS-29, a new post-dialysis recovery time module, the MOS-Social Support Scale (MOS-SSS), Subscales of the KDQOL SF 1.3 (sexual function & cognitive function), the General Self-Efficacy Scale and the Health Services Utilization And Productivity Loss Survey which are to be delivered together on a tablet computer.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent signed and dated by study patient and investigator/authorized physician
  • Age of 18 -80 years
  • Ability to understand the nature and requirements of the study
  • Literacy in Turkish including the ability to read with regards to visual acuity and the ability to understand what is read
  • General ability to use a tablet (the study nurse will instruct the patient how to use the study-tablet during the conduct of the study)
  • To be on stable maintenance hemodialysis (HD) for over 3 months (prevalent patients)

排除标准

  • Any conditions which could interfere with the patient's ability to comply with the study
  • Previous participation in the same study
  • Participation in an interventional clinical study during the preceding 30 days
  • Serious life-limiting co-morbid situations, namely active malignancy, active infection, end-stage cardiac, pulmonary, or hepatic disease, which causes life-expectancy less than a year,
  • Acute cardiovascular events including myocardial infarction, stroke and unstable angina pectoris requiring hospitalization within the last 6 months,
  • To have cognitive or mental co-morbidities which prevent reliable answering of questions

结局指标

主要结局

Validation of Patient Reported Outcome Measures Information System-29 (PROMIS-29)

时间窗: 2 weeks between test and retest

Translating and testing PROMIS Cognitive Function and Abilities Subscale (PROMIS-CFS)

时间窗: 2 weeks between test and retest

Translating and testing feasibility of a new post-dialysis recovery time module adapted from PROMIS scale on fatigue

时间窗: Single Administration in cross-sectional design

Testing feasibility of the Telephone Cognitive Screen (T-Cog-S)

时间窗: Single Administration in cross-sectional design

Testing feasibility and usefulness of measuring Social Support, potential reduction of items and internal consistency of the MOS-Social Support Scale (MOS-SSS)

时间窗: Single Administration in cross-sectional design

Assessing feasibility and usefulness of measuring General Self-Efficacy Scale (GSE)

时间窗: Single Administration in cross-sectional design

Testing feasibility of the kidney disease targeted subscales (sexual function & cognitive function) of the Kidney Disease Quality of Life Short Form Version 1.3 (KDQOL SF 1.3)

时间窗: Single Administration in cross-sectional design

Testing feasibility of Health Services Utilization and Productivity Loss Survey

时间窗: Single Administration in cross-sectional design

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验